SCHOTT Pharma AG & Co KgaA

XETRA:1SXP

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 1SXP's stock price target?

Price Target

39.44 EUR

According to Wall Street analysts, the average 1-year price target for 1SXP is 39.44 EUR with a low forecast of 30.3 EUR and a high forecast of 47.25 EUR.

What is SCHOTT Pharma AG & Co KgaA's Revenue forecast?

Projected CAGR

14%

For the last 2 years the compound annual growth rate for SCHOTT Pharma AG & Co KgaA's revenue is 18%. The projected CAGR for the next 3 years is 14%.

What is SCHOTT Pharma AG & Co KgaA's Operating Income forecast?

Projected CAGR

21%

For the last 2 years the compound annual growth rate for SCHOTT Pharma AG & Co KgaA's operating income is 22%. The projected CAGR for the next 3 years is 21%.

What is SCHOTT Pharma AG & Co KgaA's Net Income forecast?

Projected CAGR

16%

For the last 2 years the compound annual growth rate for SCHOTT Pharma AG & Co KgaA's net income is 23%. The projected CAGR for the next 3 years is 16%.